Daily summaries

Big-money moves in the US on 25/11/12 (Wed)

Insider buys
327 trades
Insider sales
872 trades
Congress trades
1 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

  • 7 Cooperative Ua Lsp

    BuyEvommune

    $25M

    Filed 25/11/12

  • Edward A. Mule

    BuyKeenova Therapeutics

    $27.2M

    Filed 25/11/12

  • Silver Point Capital

    BuyKeenova Therapeutics

    $27.2M

    Filed 25/11/12

  • Robert J. O'Shea

    BuyKeenova Therapeutics

    $27.2M

    Filed 25/11/12

  • Adam Matthew Schwartz Forste

    BuyLineage

    $2.5M

    Filed 25/11/12

  • $25M

    Filed 25/11/12

  • Ra Capital Management

    BuyEvommune

    $18.5M

    Filed 25/11/12

  • Felix Baker

    BuyEntrada Therapeutics

    $625.2K

    Filed 25/11/12

  • Julian Baker

    BuyEntrada Therapeutics

    $625.2K

    Filed 25/11/12

  • Baker Bros. Advisors

    BuyEntrada Therapeutics

    $625.2K

    Filed 25/11/12

  • Baker Bros. Advisors

    BuyEntrada Therapeutics

    $625.2K

    Filed 25/11/12

  • Robert P. Goodman

    BuyACV Auctions

    $5.1M

    Filed 25/11/12

  • Peter Konieczny

    BuyAmcor

    $504.6K

    Filed 25/11/12

  • Kevin Patrick Marchetti

    BuyLineage

    $488.9K

    Filed 25/11/12

  • Scott T. Ford

    BuyWestrock Coffee

    $435K

    Filed 25/11/12

  • Greenbrier Holdings

    BuyWestrock Coffee

    $435K

    Filed 25/11/12

  • Westrock Group

    BuyWestrock Coffee

    $435K

    Filed 25/11/12

  • $2.9M

    Filed 25/11/12

  • Haveli Investment Management

    BuyBlend Labs

    $2.9M

    Filed 25/11/12

  • Haveli Investments

    BuyBlend Labs

    $2.9M

    Filed 25/11/12

  • Haveli Software Management

    BuyBlend Labs

    $2.9M

    Filed 25/11/12

  • Brian Niranjan Sheth

    BuyBlend Labs

    $2.9M

    Filed 25/11/12

  • Whanau Interests

    BuyBlend Labs

    $2.9M

    Filed 25/11/12

  • Haveli Brooks Aggregator

    BuyBlend Labs

    $2.9M

    Filed 25/11/12

  • David W. Hass

    BuyPrimo Brands

    $249.9K

    Filed 25/11/12

  • Baker Bros. Advisors

    BuyEntrada Therapeutics

    $232.8K

    Filed 25/11/12

  • Felix Baker

    BuyEntrada Therapeutics

    $232.8K

    Filed 25/11/12

  • Baker Bros. Advisors

    BuyEntrada Therapeutics

    $232.8K

    Filed 25/11/12

  • Julian Baker

    BuyEntrada Therapeutics

    $232.8K

    Filed 25/11/12

  • Whanau Interests

    BuyBlend Labs

    $2.1M

    Filed 25/11/12

  • Haveli Investment Management

    BuyBlend Labs

    $2.1M

    Filed 25/11/12

  • Haveli Investments

    BuyBlend Labs

    $2.1M

    Filed 25/11/12

  • Brian Niranjan Sheth

    BuyBlend Labs

    $2.1M

    Filed 25/11/12

  • Haveli Software Management

    BuyBlend Labs

    $2.1M

    Filed 25/11/12

  • $2.1M

    Filed 25/11/12

  • Haveli Brooks Aggregator

    BuyBlend Labs

    $2.1M

    Filed 25/11/12

  • $189.5K

    Filed 25/11/12

  • Felix Baker

    BuyEntrada Therapeutics

    $182.9K

    Filed 25/11/12

  • Julian Baker

    BuyEntrada Therapeutics

    $182.9K

    Filed 25/11/12

  • Baker Bros. Advisors

    BuyEntrada Therapeutics

    $182.9K

    Filed 25/11/12

  • Baker Bros. Advisors

    BuyEntrada Therapeutics

    $182.9K

    Filed 25/11/12

  • Haveli Investment Management

    BuyBlend Labs

    $1.8M

    Filed 25/11/12

  • Haveli Software Management

    BuyBlend Labs

    $1.8M

    Filed 25/11/12

  • $1.8M

    Filed 25/11/12

  • Whanau Interests

    BuyBlend Labs

    $1.8M

    Filed 25/11/12

  • Haveli Investments

    BuyBlend Labs

    $1.8M

    Filed 25/11/12

  • Haveli Brooks Aggregator

    BuyBlend Labs

    $1.8M

    Filed 25/11/12

  • Brian Niranjan Sheth

    BuyBlend Labs

    $1.8M

    Filed 25/11/12

  • Ra Capital Management

    BuyEvommune

    $1.5M

    Filed 25/11/12

  • Laurence Neil Hunn

    BuyRoper Technologies

    $3.6M

    Filed 25/11/12